02877 SHINEWAY PHARM
Closed Add to Porfolio| Key Financial Ratio (Fiscal Year: 12/2024) | |||
| Current | 3.51X | Oper Margin | 30.5% |
|---|---|---|---|
| LT Debt/Equity | 0.1% | Net Margin | 22.2% |
| Total Debt/Equity | 4.6% | Return on Equity | 11.3% |
| Price/Book | 0.86X | Return on Assets | 8.4% |
| (HKD 8.250) | 2024-12 | 2023-12 | 2022-12 | 2021-12 | 2020-12 |
| Net Profit (MHKD) | 893.40 | 1,068.59 | 810.37 | 680.87 | 350.15 |
|---|---|---|---|---|---|
| Net Profit Growth (%) | -16.4 | +31.9 | +19.0 | +94.5 | -37.8 |
| Earnings Per Share (HKD) | 1.183 | 1.415 | 1.073 | 0.902 | 0.463 |
| Earnings Per Share Growth (%) | -16.4 | +31.9 | +19.0 | +94.9 | -35.8 |
| Dividend Per Share (HKD) | 0.966 | 0.471 | 0.383 | 0.470 | 0.380 |
| P/E* (X) | 6.98 | 5.83 | 7.69 | 9.15 | 17.83 |
| Yield (%) | 11.71 | 5.71 | 4.64 | 5.69 | 4.60 |
| Dividend Share (%) | 81.68 | 33.30 | 35.70 | 52.09 | 82.08 |
| Book NAV (HKD) | 9.602 | 9.376 | 8.653 | 8.728 | 8.315 |
| Auditors' Opinion | Unqualified | Unqualified | Unqualified | Unqualified | Unqualified |
Remarks:
1. Unqualified = Not Qualified because the financial statements have been fairly presented in accordance with appropriate accounting standards and companies ordinance.
2. Unqualified # = Not Qualified in respect of fundamental uncertainty because of appropriate disclosures.
3. Qualified = Qualified Opinion in respect of limitation in audit scope and/or disclaimer on view given by financial statements and/or disagreement of accounting treatment and/or adverse opinion.
1. Unqualified = Not Qualified because the financial statements have been fairly presented in accordance with appropriate accounting standards and companies ordinance.
2. Unqualified # = Not Qualified in respect of fundamental uncertainty because of appropriate disclosures.
3. Qualified = Qualified Opinion in respect of limitation in audit scope and/or disclaimer on view given by financial statements and/or disagreement of accounting treatment and/or adverse opinion.
Last Update Time: 2025-07-22 21:40:20
Latest Result
| (RMBMn) | 2024-12 | 2023-12 | Chg* (%) | 2022-12 |
| Cover Period (mths) | 12 | 12 | NA | 12 |
|---|---|---|---|---|
| Turnover | 3,778 | 4,517 | -16.4 | 3,951 |
| Operating Result | 1,146 | 1,240 | -7.6 | 917.025 |
| Profit Before Taxation | 1,146 | 1,240 | -7.6 | 917.025 |
| Taxation | 305.669 | 270.743 | +12.9 | 194.252 |
| Profit /( Loss) After Taxation | 840.052 | 969.51 | -13.4 | 722.773 |
| Net Profit | 840.052 | 969.51 | -13.4 | 722.773 |
| Earnings Per Share () | 1.1827 | 1.4146 | -16.4 | 1.0728 |
| Dividend Per Share () | 0.9660 | 0.4710 | +105.1 | 0.3830 |
| Announcement Date | 2025-03-28 | 2024-03-28 | NA | 2023-03-30 |
* Annualised
Last Update Time: 2025-07-22 21:40:25
